Readily vs Isomorphic Labs
Side-by-side comparison of features, pricing, and ratings
At a glance
| Dimension | Readily | Isomorphic Labs |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing (enterprise partnerships) |
| Target User | Healthcare compliance officers, regulatory affairs managers | Pharma companies, large-scale drug developers |
| Core Technology | AI-powered search and gap analysis for regulations and internal documents | Predictive and generative AI for protein-ligand interactions (AlphaFold-based) |
| Business Model | Direct SaaS sales to healthcare organizations | Deep pharma collaborations (Novartis, Johnson & Johnson), not a product company |
| Latest News | No recent news captured | Series B (2026-05-12), $600M investment (2025-03-31), J&J collaboration (2026-01-20) |
| Not For | Non-healthcare compliance, teams without document base, or seeking free tool | Individual researchers, startups without pharma partnerships, those needing transparent pricing |
Readily and Isomorphic Labs operate in entirely different domains: Readily addresses healthcare compliance with AI-powered regulatory automation, while Isomorphic Labs is a frontier AI drug discovery engine for pharma partnerships. For a compliance team, Readily provides immediate operational value; for a pharma company seeking to accelerate drug design, Isomorphic's AlphaFold-based partnerships are the only route. They are not directly substitutable.
AI-native healthcare compliance platform that connects regulations to policies, contracts, and case files for audit readiness.
Visit Website
What real users say: Readily vs Isomorphic Labs
Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.
Readily
47 mentions across 3 sources · 17% positive — critical
Hacker News, App Store, Lemmy
What users praise
- • Automates regulatory gap analysis for healthcare compliance teams.
- • Unifies external regulations and internal documents in one knowledge base.
- • Version-controlled documents reduce compliance audit preparation time.
- • AI search can locate specific language within hundreds of pages.
What frustrates them
- • Zero community validation from healthcare compliance users.
- • App Store reviews likely for a different product with same name.
- • No evidence of reliability, accuracy, or support quality.
- • Cannot verify gap analysis or audit prep effectiveness.
Researched Jul 3, 2026
Isomorphic Labs
48 mentions across 3 sources · 82% positive
Hacker News, YouTube, Lemmy
What users praise
- • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
- • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
- • Deep partnerships with Novartis and J&J, with potential billions in royalties.
- • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.
What frustrates them
- • Not accessible to individual researchers or small biotech due to partnership model only.
- • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
- • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
- • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.
Researched Aug 18, 2026
Who should pick which
- Healthcare compliance officerPick: Readily
Readily directly automates regulatory search, gap analysis, and audit prep for healthcare organizations, saving hours of manual work.
- Pharma R&D VP seeking AI drug discovery partnerPick: Isomorphic Labs
Isomorphic Labs offers AlphaFold-based predictive and generative models for drug design, proven through partnerships with Novartis and Johnson & Johnson.
- Regulatory affairs manager at a hospitalPick: Readily
Readily's features for tracking All Plan Letters, analyzing bills, and identifying impacted departments are tailored to healthcare regulatory workflows.
- Biotech startup evaluating AI tools for lead optimizationPick: Isomorphic Labs
Isomorphic Labs' Drug Design Engine and digital biology simulation could accelerate lead optimization, but only via a partnership; not a off-the-shelf solution.
- Audit preparation team in a health planPick: Readily
Readily reduces audit findings with prepared documentation and version-controlled knowledge base, directly addressing audit pain points.
Frequently Asked Questions
Readily vs Isomorphic Labs: which should you choose?
Readily and Isomorphic Labs operate in entirely different domains: Readily addresses healthcare compliance with AI-powered regulatory automation, while Isomorphic Labs is a frontier AI drug discovery engine for pharma partnerships. For a compliance team, Readily provides immediate operational value; for a pharma company seeking to accelerate drug design, Isomorphic's AlphaFold-based partnerships are the only route. They are not directly substitutable.
Can Readily be used outside healthcare?
Readily is designed for healthcare organizations; its features center on healthcare regulations (e.g., All Plan Letters). It is not recommended for non-healthcare compliance teams.
Is Isomorphic Labs a software product I can buy?
No. Isomorphic Labs operates through deep pharma partnerships (Novartis, Johnson & Johnson). It does not offer a standalone product or API for individual use.
What is the latest funding news for Isomorphic Labs?
Isomorphic Labs raised a $600M external investment round in March 2025 and closed a Series B in May 2026 (amount undisclosed). It also has collaborations with Novartis and Johnson & Johnson.
Does Readily have any recent news?
No recent news was captured for Readily in the provided data.
Can Isomorphic Labs help with drug repurposing or small molecule screening?
While it could theoretically be applied, Isomorphic Labs focuses on large-scale drug development partnerships for novel molecules, not short-term repurposing or screening projects.
What integrations does Readily offer?
The provided data does not list specific integrations for Readily.
What integrations does Isomorphic Labs offer?
No integrations are listed; Isomorphic Labs operates as a research partner, not a platform with third-party integrations.
Who leads Isomorphic Labs?
Sir Demis Hassabis is the founder. Max Jaderberg is President (appointed Nov 2025), and Dr. Ben Wolf is Chief Medical Officer (appointed June 2025).
More Readily or Isomorphic Labs comparisons
Angle and Isomorphic Labs serve completely different domains—Angle is a free, niche pose-measurement tool for fitness professionals, while Isomorphic Labs is an enterprise AI drug discovery platform f
Choose Ray if you need an adaptive, low-barrier AI personal trainer for flexible, voice-guided workouts — it's ideal for busy individuals wanting consistency without gym intimidation. Choose Isomorphi
These tools are polar opposites in audience and purpose. Ironclaw AI Vision is a free, offline-first PWA for individual fitness tracking with AI coaching and meal planning – ideal for privacy-consciou
These tools serve completely different markets. CalBye is a consumer nutrition app for individuals wanting effortless calorie tracking via photos, while Isomorphic Labs is an enterprise drug discovery
MediSphere and Isomorphic Labs serve completely different healthcare verticals. Choose MediSphere if you run a small clinic needing AI-powered administration, no-show prediction, and EHR. Choose Isomo
Isomorphic Labs and Swimio serve completely different worlds: one is a high-stakes pharma AI platform for billion-dollar drug programs, the other a consumer fitness app for swimmers. Choose based on y
Explore each tool further
Browse these categories
One email a week — new tools, honest comparisons, no spam.
Last reviewed: July 3, 2026